Literature DB >> 24312762

Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.

Negar Bashardoust1, Josephine Leno Jenita, Parvin Zakeri-Milani.   

Abstract

PURPOSE: The aim of the present study was minimizing the drug release in upper gastro intestinal tract and targeting to colon by using the principles of compression coat.
METHODS: Compression coated tablets of Ibuprofen were prepared by direct compression method using chitosan (300, 250, 200 & 175 mg). Tablets were evaluated for their physicochemical properties and in vitro drug release studies. In vitro drug release studies were performed with and without rat caecal contents.
RESULTS: In the rat caecal contents tablets showed enhanced drug release due to degradation of chitosan coat by colonic colonic enzymes. The in vitro release studies in pH-6.8 phosphate buffer containing 2% w/v of rat caecal contents showed the cumulative percentage release of Ibuprofen after 26h as 31.94% ±0.59, 67.89% ± 0.45 and 55.87 % ± 0.45 and 82.52 % ± 0.92 respectively. Coat thickness and amount of chitosan controls the release rate. Formulations are best fitted with Korsmeyer-Peppas kinetics and mechanism of drug release was non-Fickian. FTIR studies reveals there is no drug-polysaccharide interaction. F1 formulation was a promising system for drug targeting to colon.
CONCLUSION: Based on the obtained results chitosan as a press coat could target ibuprofen to the colon.

Entities:  

Keywords:  Chitosan; Colon targeting; Compressed coated; Ibuprofen; Polysaccharide; Tablet

Year:  2011        PMID: 24312762      PMCID: PMC3845982          DOI: 10.5681/apb.2011.013

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  7 in total

Review 1.  Bacteria and pH-sensitive polysaccharide-polymer films for colon targeted delivery.

Authors:  Fredrick Esseku; Moji Christianah Adeyeye
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2011       Impact factor: 4.889

2.  An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting.

Authors:  Chellan Vijaya Raghavan; Chithambaram Muthulingam; Joseph Amaladoss Josephine Leno Jenita; Thengungal Kochupapy Ravi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-07       Impact factor: 1.645

3.  Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis.

Authors:  Y S R Krishnaiah; Y Indira Muzib; G Srinivasa Rao; P Bhaskar; V Satyanarayana
Journal:  Drug Deliv       Date:  2003 Apr-Jun       Impact factor: 6.419

Review 4.  Current applications of polysaccharides in colon targeting.

Authors:  L Hovgaard; H Brøndsted
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1996       Impact factor: 4.889

5.  Formulation development of carvedilol compression coated tablet.

Authors:  Ritesh Shah; Sachin Patel; Hetal Patel; Sonia Pandey; Shailesh Shah; Dinesh Shah
Journal:  Pharm Dev Technol       Date:  2011-07-28       Impact factor: 3.133

6.  Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.

Authors:  V R Sinha; B R Mittal; K K Bhutani; Rachna Kumria
Journal:  Int J Pharm       Date:  2004-01-09       Impact factor: 5.875

7.  Release kinetic studies of aspirin microcapsules from ethyl cellulose, cellulose acetate phthalate and their mixtures by emulsion solvent evaporation method.

Authors:  Vikas Dash; Sujeet K Mishra; Manoj Singh; Amit K Goyal; Goutam Rath
Journal:  Sci Pharm       Date:  2009-12-19
  7 in total
  2 in total

1.  Preparation, Evaluation and Optimization of Multiparticulate System of Mebendazole for Colon Targeted Drug Delivery by Using Natural Polysaccharides.

Authors:  Kuldeep Hemraj Ramteke; Varsha Balaji Jadhav; Nilesh Shrikant Kulkarni; Amol Rameshrao Kharat; Sonali Bhima Diwate
Journal:  Adv Pharm Bull       Date:  2015-09-19

2.  Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy.

Authors:  Pooja Mongia Raj; Rakesh Raj; Ankur Kaul; Anil K Mishra; Alpana Ram
Journal:  RSC Adv       Date:  2018-06-06       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.